Effects of mechano-gated cation channel blockers on Xenopus oocyte growth and development.
The putative role(s) of a mechanically gated (MG) cation channel in Xenopus oocyte growth, maturation, fertilization and embryogenesis has been examined. Using a pharmacological approach, we have tested the effects of the MG channel blockers, gadolinium, gentamicin and amiloride on the above developmental events. Our results indicate that oocyte maturation, fertilization and early embryogenesis (up to the free-swimming stage 45) can proceed normally in the presence of concentrations of agents that either completely abolish (i.e., > or = 10 microM Gd3+) or partially block (i.e., 1 mM gentamicin) single MG channel activity as measured by patch-clamp recording. However, we also find that higher concentrations of Gd3+ (> or = 50 microM) can lead to an increased percentage (> 20%) of axis-perturbed embryos compared with control (< 1%) and that amiloride (0.5 mM) reduces the success of fertilization (from 100% to < 50%) and increases mortality (by approximately 75%) in developing embryos. Furthermore, we find that all three agents inhibit oocyte growth in vitro. However, their order of effectiveness (amiloride > gentamicin > Gd3+) is opposite to their order for blocking MG channels (Gd3+ >> gentamicin > amiloride). These discrepancies indicated that the drugs effects occur by mechanisms other than, or in addition to, MG channel block. Our results provide no compelling evidence for the idea that MG channel activity is critical for development in Xenopus. This could mean that there are other mechanisms in the oocyte that can compensate when MG channel activity is blocked or that the protein that forms the channel can undergo additional interactions that result in a function insensitive to MG channel blockers.
Wilkinson
N C
NC
Department of Physiology and Biophysics, University of Texas Medical Branch, Galveston 77555-0641, USA.
Gao
F
F
Hamill
O P
OP
D000584:Amiloride / Q000494:pharmacology*; D000818:Animals; D002454:Cell Differentiation / Q000187:drug effects; D004232:Diuretics / Q000494:pharmacology*; D004625:Embryo, Nonmammalian / Q000187:drug effects*; D005682:Gadolinium / Q000494:pharmacology*; D005839:Gentamicins / Q000494:pharmacology*; D015640:Ion Channel Gating / Q000187:drug effects; D007473:Ion Channels / Q000037:antagonists & inhibitors*; D009865:Oocytes / Q000166:cytology / Q000187:drug effects* / Q000254:growth & development; D014981:Xenopus
D004232:Diuretics; D005839:Gentamicins; D007473:Ion Channels; D000584:Amiloride; D005682:Gadolinium